Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 104
Filter
1.
J Endocrinol Invest ; 44(4): 679-691, 2021 Apr.
Article in English | MEDLINE | ID: mdl-32780357

ABSTRACT

Goiters tend to grow slowly and steadily over many years, occasionally reaching the mediastinum and extending through the thoracic inlet into the visceral compartment. In most cases, retrosternal goiters originate from the cervical portion of the thyroid. The incidence of retrosternal goiters varies considerably, ranging from 0.2 to 45% of all thyroidectomies, depending on the criteria used to define this type of goiter. Symptoms are generally related to the compressive nature of the mass on the adjacent structures, and most patients report some form of respiratory manifestation associated with the goiter. A diagnostic assessment usually includes an evaluation of thyroid function, chest radiography, and computed tomography. Fine-needle aspiration biopsy should be avoided in substernal areas of the goiter due to limited visibility and location of vital structures in this region. Treatment of retrosternal goiters is surgical, as medical therapy is generally unsuccessful in these cases.


Subject(s)
Goiter, Substernal , Thyroidectomy/methods , Goiter, Substernal/diagnosis , Goiter, Substernal/epidemiology , Goiter, Substernal/physiopathology , Goiter, Substernal/surgery , Humans , Incidence , Radiography, Thoracic/methods , Thyroid Function Tests/methods , Thyroid Gland/diagnostic imaging
2.
J Endocrinol Invest ; 39(4): 357-73, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26392367

ABSTRACT

Goiter, an enlargement of the thyroid gland, is a common problem in clinical practice associated with iodine deficiency, increase in serum thyroid-stimulating hormone (TSH) level, natural goitrogens, smoking, and lack of selenium and iron. Evidence suggests that heredity also has an important role in the etiology of goiter. The current classification divides goiter into diffuse and nodular, which may be further subdivided into toxic (associated with symptoms of hyperthyroidism, suppressed TSH or both), or nontoxic (associated with a normal TSH level). Nodular thyroid disease with the presence of single or multiple nodules requires evaluation due to the risk of malignancy, toxicity, and local compressive symptoms. Measurement of TSH, accurate imaging with high-resolution ultrasonography or computed tomography, and fine-needle aspiration biopsy are the appropriate methods for evaluation and management of goiter. This review discusses the clinical presentation, diagnostic evaluation, and treatment considerations of nontoxic diffuse and nodular goiters.


Subject(s)
Goiter, Nodular/pathology , Goiter, Nodular/therapy , Goiter, Nodular/etiology , Humans , Prognosis
3.
J Endocrinol Invest ; 38(10): 1065-74, 2015 Oct.
Article in English | MEDLINE | ID: mdl-25894865

ABSTRACT

PURPOSE: To analyze the impact of selenium supplementation on serum antiTPO levels and thyroid echogenicity in patients with CAT, evaluating the response in subgroups with different GPx1 genotypes. METHODS: CAT patients (n = 55) with positive antiTPO were randomized to selenomethionine (SeMet) 200 µg daily (n = 28) or placebo (n = 27) for 3 months. Assessments included GPx1 genotyping at baseline and serum levels of plasma selenium, erythrocyte GPx1 activity, antiTPO and thyroid echogenicity at baseline, and 3 and 6 months. RESULTS: In the SeMet group, the increase in plasma levels of selenium and erythrocyte GPx1 activity was similar among patients with different GPx1 genotypes. In the overall cohort, patients randomized to SeMet showed a 5 % decrease in antiTPO levels at 3 months (p = non-significant) and 20 % at 6 months (p < 0.001 versus 3 months). In contrast, patients in the placebo group did not show significant changes in antiTPO levels at any time point. Subgroup analysis showed that patients with different GPx1 genotypes presented comparable responses in antiTPO levels and echogenicity index to SeMet. CONCLUSIONS: Selenium supplementation decreased serum antiTPO levels in CAT patients, with similar response among patients with different GPx1 genotypes.


Subject(s)
Autoimmunity/drug effects , Dietary Supplements , Glutathione Peroxidase/genetics , Iodide Peroxidase/immunology , Selenomethionine/therapeutic use , Thyroid Gland/drug effects , Thyroiditis, Autoimmune/drug therapy , Adult , Double-Blind Method , Female , Genotype , Humans , Inflammation/drug therapy , Inflammation/genetics , Inflammation/immunology , Male , Middle Aged , Selenomethionine/administration & dosage , Thyroid Gland/immunology , Thyroiditis, Autoimmune/genetics , Thyroiditis, Autoimmune/immunology , Treatment Outcome , Young Adult , Glutathione Peroxidase GPX1
4.
J Phys Chem A ; 117(11): 2400-7, 2013 Mar 21.
Article in English | MEDLINE | ID: mdl-23448236

ABSTRACT

When 1-methyl-2-pyrrolidone molecule (1m2p) interacts with the T[Ni(CN)4] layer, its carbonyl π bond homolytically disrupts and forms a coordination bond at the axial positions for the metal T, and hybrid inorganic-organic solids of formula unit T(L)2[Ni(CN)4], with T = Mn, Co, Ni, are obtained. The formed solids crystallize with a monoclinic unit cell in the C2/m space group where the metal T is found with octahedral coordination to four N ends of CN groups from a given layer and to two oxygen atoms from the organic ligands, while the inner metal (Ni) preserves its square planar coordination. In the interlayer region, the organic molecules achieve unusual planarity and are stacked through dipole-dipole interactions in a head-to-tail configuration to form a chain of molecular pillars. From such interactions, 3D pillared hybrid solids result. Upon the charge donation to the metal by oxygen atom from 1m2p, the latter becomes an organic radical whose SOMO frontier orbital has a strong π character, associated with an essentially planar structure. The unpaired electron is delocalized between neighboring C and N atoms at the ligand ring plane, and it is featured by an outstanding broad absorption band in the near-IR region. For Ni, the metal of highest polarizing power within the considered series, the existence of π overlapping interaction between organic ligand molecules leads to ferromagnetic ordering at low temperature, with TC = 10.07 K. For Mn and Co, related to the lower metal electron-withdrawing ability, the materials maintain the weak antiferromagnetic character resulting from the interaction between T metals in the layer -T-N≡C-Ni-C≡N-T- chains.

5.
J Nanosci Nanotechnol ; 11(1): 555-9, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21446496

ABSTRACT

This paper reports the effect of Fe doping on the structure and room temperature ferromagnetism of CeO2 nanoparticles. X-ray diffraction and the selective area electron diffraction measurements performed on the Ce(1-x)Fe(x)O2 (0 < or = x < or = 0.07) nanoparticles showed a single-phase nature with a cubic structure, and none of the samples showed the presence of any secondary phase. The mean particle size, which was calculated using transmission electron microscopy, increased with the increase in the Fe content. The DC magnetization measurements that were performed at room temperature showed that all the samples exhibited ferromagnetism. The saturation magnetic moment increased with the increase in the Fe content.

6.
Nanotechnology ; 21(3): 035602, 2010 Jan 22.
Article in English | MEDLINE | ID: mdl-19966407

ABSTRACT

We report an alternative synthesis method and novel magnetic properties of Ni-oxide nanoparticles (NPs). The NPs were prepared by thermal decomposition of nickel phosphine complexes in a high-boiling-point organic solvent. These particles exhibit an interesting morphology constituted by a crystalline core and a broad disordered superficial shell. Our results suggest that the magnetic behavior is mainly dominated by strong surface effects at low temperature, which become evident through the observation of shifted hysteresis loops (approximately 2.2 kOe), coercivity enhancement (approximately 10.2 kOe) and high field irreversibility (>or=50 kOe). Both an exchange bias and a vertical shift in magnetization can be observed in this system below 35 K after field cooling. Additionally, the exchange bias field shows a linear dependence on the magnetization shift values, which elucidate the role of pinned spins on the exchange fields. The experimental data are analyzed in terms of the interplay between the interface exchange coupling and the antiferromagnetically ordered structure of the core.

7.
J Phys Condens Matter ; 21(3): 035301, 2009 Jan 21.
Article in English | MEDLINE | ID: mdl-21817277

ABSTRACT

We report on the fabrication, and structural and magnetic characterization of Cu(63)Fe(37) microwires with granular structure produced by rapid quenching, using the Tailor-Ulitovsky method, from the immiscible alloys. X-ray diffraction study demonstrated that the structure consists of small (6-45 nm) crystallites of Cu and body centred cubic α-Fe. Magnetic properties have been measured in the range of 5-300 K using a SQUID (superconducting quantum interference device) magnetometer. The temperature dependences of the magnetization measured in a cooling regime when no external magnetic field is applied (zero-field cooling) and in the presence of the field (field cooling) show considerable difference below 20 K. This difference could be related to the presence of small α-Fe grains embedded in the Cu matrix. Those α-Fe grains appear to be blocked at temperatures below that at which the maximum of the magnetization is observed in the low temperature range. Significant magnetoresistance (about 7%) has been found in the samples studied. The shape of the observed dependences is typical of a giant magnetoresistance effect.

8.
J Nanosci Nanotechnol ; 8(6): 2836-57, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18681019

ABSTRACT

An overview on magnetic of nanostructured magnetic materials is presented, with particular emphasis on the basic features displayed by granular nanomagnetic solids. Besides a review of the basic concepts and experimental techniques, the role of structural disorder (mainly the distribution of grain sizes), interparticle magnetic interactions and surface effects are also discussed with some detail. Recent results, models and trends on the area are also discussed.

9.
J Phys Condens Matter ; 20(23): 235214, 2008 Jun 11.
Article in English | MEDLINE | ID: mdl-21694305

ABSTRACT

We present here a detailed investigation of the static and dynamic magnetic behavior of a Mg(0.95)Mn(0.05)Fe(2)O(4) spinel ferrite nanoparticle system synthesized by high-energy ball milling of almost identical particle size distributions ([Formula: see text], 5.1 and 6.0 ± 0.6 nm). The samples were characterized by using x-ray diffraction, Mössbauer spectroscopy, dc magnetization and frequency dependent real χ(')(T) and imaginary χ('')(T) parts of ac susceptibility measurements. The zero-field-cooled (ZFC) and field-cooled (FC) magnetization have been recorded in a low field and show a behavior typical of superparamagnetic particles above a temperature of 185 ± 5 K, which is further supported from the temperature dependent Mössbauer measurements. The fact that the blocking temperature calculated from the ZFC magnetization and Mössbauer data are almost similar gives a clear indication of the interparticle interactions among these nanoparticle systems. This is further supported from the FC magnetization curves, which are almost flat below a certain temperature (less than the blocking temperature), as compared with the monotonically increasing behavior characteristics of non-interacting superparamagnetic particles. A shift of the blocking temperature with increasing frequency was observed in the real χ(')(T) and imaginary χ('')(T) parts of the ac susceptibility measurements. The analysis of the results shows that the data fit well with the Vogel-Fulcher law, whereas trials using the Neel-Brown and power law are unproductive. The role of magnetic interparticle interactions on the magnetic behavior, namely superparamagnetic relaxation time and magnetic anisotropy, are discussed.

10.
J Nanosci Nanotechnol ; 7(9): 3313-7, 2007 Sep.
Article in English | MEDLINE | ID: mdl-18019166

ABSTRACT

Morphological, structural and magnetic properties of 4.8 nm iron oxide nanoparticles have been investigated after annealing under inert atmosphere at different temperatures. The as-prepared iron oxide nanoparticles have been synthesized by chemical route from high temperature reaction of Fe(acac)3 solution in presence of oleic acid and oleylamine surfactant. Annealing the particles at low temperatures (Tann = 573 K) produces an increment of the mean size from 4.8 nm to 6.0 nm, preserving the same morphology. The coercive field of the annealed sample has a small increasing with respect to the as-prepared sample in agreement with the mean particle volume change. Annealing at higher temperature (Tann = 823 K) leads to a bimodal size distribution of the iron oxide nanoparticles with 6.0 nm and 17 nm mean sizes respectively, where the bigger particles dominate the observed magnetic properties.


Subject(s)
Ferric Compounds/chemistry , Metal Nanoparticles/chemistry , Nanotechnology/methods , Amines/chemistry , Ferrosoferric Oxide/chemistry , Iron/chemistry , Magnetics , Microscopy, Electron, Transmission , Nanoparticles/chemistry , Nanostructures/chemistry , Oleic Acid/chemistry , Particle Size , Surface-Active Agents/chemistry , Temperature , X-Ray Diffraction
11.
J Endocrinol Invest ; 30(7): 535-40, 2007.
Article in English | MEDLINE | ID: mdl-17848834

ABSTRACT

We investigated the effect of therapeutic doses of radioiodine (RAI) on peripheral serum messenger thyroglobulin RNA (Tg mRNA) and serum thyroglobulin (sTg) in patients with multinodular goiter (MNG) preceded or not by treatment with recombinant human TSH (rhTSH). Fourteen patients with large MNG (91-542 ml) received RAI (550-2960 MBq). Half of the patients received 0.45 mg of rhTSH prior to the treatment (RAI+rhTSH group) and half did not (RAI group). Patients' blood samples were collected before and 24, 48, and 72 h; 7 and 30 days; and 6, 9, and 12 months after RAI treatment. Serum Tg was measured by immunoradiometric assay, serum anti-Tg by radioimmunoassay, and quantification of circulating Tg mRNA was performed by real-time PCR. The shrinkage of MNG volume was documented by serial computed tomography (CT) scans before, 6 and 12 months after RAI. Peak Tg mRNA and sTg were reached earlier in the RAI+rhTSH group (24 h and 48 h) than in the RAI group (7 days). Both declined after the peak and the lowest levels were observed at 12 months. The mean reduction of the thyroid volume was 19.8% (RAI group) and 30.3% (RAI+rhTSH group) at 6 months (ns) and 32.8% RAI and 52.5% (RAI+rhTSH group) at 12 months (p<0.05). After RAI treatment there was a significant and positive correlation between goiter volume and sTg only in the RAI group (r=0.7; p=0.032). Serum anti-Tg had a transitory and relatively small elevation in 3 and 2 patients, respectively, in the RAI and RAI+rhTSH groups. We concluded that after RAI ablation of MNG there is a rapid release of Tg into the serum possibly from the colloid, which is followed by an elevation of serum Tg mRNA that may be due to an increased release of follicular cells into the blood stream. Both phenomena are enhanced by the use of rhTSH before RAI treatment as a consequence of a more effective and prolonged radiation exposure of the thyroid follicles.


Subject(s)
Goiter, Nodular/drug therapy , Goiter, Nodular/radiotherapy , Iodine Radioisotopes/therapeutic use , Thyroglobulin/blood , Thyroglobulin/genetics , Thyrotropin/therapeutic use , Chemotherapy, Adjuvant , Combined Modality Therapy , Female , Follow-Up Studies , Goiter, Nodular/blood , Goiter, Nodular/genetics , Humans , RNA, Messenger/blood , Radiotherapy Dosage , Recombinant Proteins/therapeutic use
12.
J Phys Chem B ; 110(14): 7296-303, 2006 Apr 13.
Article in English | MEDLINE | ID: mdl-16599501

ABSTRACT

The thermal-induced changes in molecular magnets based on Prussian blue analogues, M(3)[Fe(CN)(6)](2).xH(2)O (M = Mn, Co, Ni, Cu, Zn, and Cd), were studied from infrared, X-ray diffraction, thermo-gravimetric, Mössbauer, and magnetic data. Upon being heated, these materials loose the crystalline water that enhances the interaction between the metal centers, as has been detected from Mössbauer spectroscopy data. At higher temperatures, a progressive decomposition process takes place, liberating CN(-) groups, which reduces the iron atom from Fe(III) to Fe(II) to form hexacyanoferrates(II). The exception corresponds to the cobalt compound that undergoes an inner charge transfer to form Co(III) hexacyanoferrate(II). In the case of zinc ferricyanide, the thermal decomposition is preceded by a structural transformation, from cubic to hexagonal. For M = Co, Ni, Cu, and Zn the intermediate reaction product corresponds to a solid solution of M(II) ferricyanide and ferrocyanide. For M = Mn and Cd the formation of a solid solution on heating was not detected. The crystal frameworks of the initial M(II) ferricyanide and of the formed M(II) ferrocyanide are quite different. In annealed Mn(II) ferricyanide samples, an increasing anti-ferromagnetic contribution on heating, which dominates on the initial ferrimagnetic order, was observed. Such a contribution was attributed to neighboring Mn(II) ions linked by aquo bridges. In the anhydrous annealed sample such interaction disappears. This effect was also studied in pure Mn(II) ferrocyanide. The occurrence of linkage isomerism and also the formation of Ni(III), Cu(III), and Zn(III) hexacyanoferrates(II) were discarded from the obtained experimental evidence.

13.
J Endocrinol Invest ; 25(2): 110-5, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11929080

ABSTRACT

Serial weekly serum samples (for 3 weeks) were obtained from 42 patients with differentiated thyroid cancer (DTC, papillary no.=35, follicular no.=6, Hurthle cell no.=1) for serum thyroid hormone, TSH and TG before and after total thyroidectomy. Serum specimens were also obtained one month after radioiodine (131I) therapy followed by suppressive dose of L-thyroxine (L-T4, 2.5 microg/kg). The patients were subdivided into four groups: group I: the DTC was confined to a single solid nodule (no.=1 2); group II: thyroid malignancy invaded local cervical structures but there were no lymph node metastases (no.=8); group III: DTC with lymph node metastases (no.=6); and group IV: DTC with distant metastases (no.=16). In all group I patients serum TG remained undetectable in spite of elevated serum TSH levels at the 3rd week post-surgery (PS). Only one of group II patients had a detectable serum TG value of 5.2 ng/ml (3rd week PS). By contrast, 37.5% of group III patients had detectable serum TG levels, ranging from 3.4 to 16.8 ng/ml (3rd week PS). Lymph node metastases were detected in 5 of these patients by whole body scan (WBS) and removed surgically in 3. As expected, group IV patients had elevated serum TG values ranging 33.0-958.0 ng/ml and distant metastases were confirmed in all of them by WBS. From the calculations through univariate logistic regression comparing TG concentrations at the 3rd week PS from groups I and II vs groups III and IV, we obtained a cut-off value of 2.3 ng/ml with the following efficacy features: sensitivity=74.5%; specificity=95%; positive predictive value=92.3%; negative predictive value=65.5%; and accuracy=73.8%. After 131I and L-T4 suppressive therapy, only 5 out of 36 patients of groups I, II and III had detectable serum TG levels (3.1-7.0 ng/ml) whereas serum TG was detectable in all group IV patients (ranging 2.5-8.6 ng/ml). We concluded that serum TG concentrations above 2.3 ng/ml at the 3rd week PS could be suggestive of lymph node or distant metastases in patients with DTC. Patients with serum TG above this limit could be considered at risk for metastatic disease and higher doses of diagnostic iodine-131 (131I) may be indicated for actinic ablation.


Subject(s)
Neoplasm Metastasis/diagnosis , Thyroglobulin/blood , Thyroid Neoplasms/blood , Thyroid Neoplasms/surgery , Thyroidectomy , Adenocarcinoma, Follicular/blood , Adenocarcinoma, Follicular/surgery , Adenocarcinoma, Follicular/therapy , Adenoma, Oxyphilic/blood , Adenoma, Oxyphilic/surgery , Adenoma, Oxyphilic/therapy , Adult , Aged , Aged, 80 and over , Carcinoma, Papillary/blood , Carcinoma, Papillary/surgery , Carcinoma, Papillary/therapy , Female , Humans , Iodine Radioisotopes/therapeutic use , Logistic Models , Lymphatic Metastasis/diagnosis , Male , Middle Aged , Prognosis , Thyroid Neoplasms/therapy , Thyrotropin/blood , Thyroxine/therapeutic use
14.
J Synchrotron Radiat ; 8(Pt 2): 877-9, 2001 Mar 01.
Article in English | MEDLINE | ID: mdl-11512964

ABSTRACT

We have studied the structure of melt-spun copper-permalloy samples (Cu80Fe4Ni16), annealed at several temperatures up to 873 K by means of EXAFS spectroscopy. The results for iron first neighhor average distance showed a slow decrease for annealing temperatures higher than 673 K. The nickel first neighbor distance had almost no change in the whole temperature range. This behavior is discussed in the light of rich iron cluster formation, and is compared with magnetic measurement results.

18.
Clin Endocrinol (Oxf) ; 53(1): 21-31, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10931077

ABSTRACT

OBJECTIVE: Postpartum thyroid dysfunction (PPTD) is an autoimmune disorder characterized by the development of transient hyperthyroidism and, more frequently, hypothyroidism (or both) during the first six months of the puerperal period. A variable incidence has been reported in part because of differences in the number of women studied, the frequency of thyroid assessment postpartum, diagnostic criteria and methodology. The aim of this study was to evaluate thyroid function, ultrasound images and titre of autoantibodies against thyroid antigens in a cohort of pregnant women who met the criteria of 'normal' thyroid gland structure on clinical examination and imaging and normal thyroid function tests without a significantly positive anti-thyroid peroxidase (TPO) antibody titre (i.e. < 100 U/ml) in the first trimester. DESIGN AND PATIENTS: Eight hundred nulliparous or multiparous (one to seven previous pregnancies) pregnant women (age 26.1 +/- 4.8 years, mean +/- SD), were submitted to clinical, laboratory and ultrasonographic examination in the first trimester of pregnancy. Among these forty-six patients were excluded because of thyroid dysfunction, ultrasound structural abnormalities or a positive anti-TPO antibody titre (> 100 U/ml). A total number of 754 women were available for further studies in the postpartum period. A relatively large number of these patients (386) were lost for follow-up either before or after delivery. MEASUREMENTS: A cohort of 368 puerperal women was followed up regularly at 3, 6, 12 and 24 months after delivery, with periodic thyroid function tests, random urine iodine measurements, assays for serum autoantibodies against thyroid antigens and imaging by ultrasound. RESULTS: The provisional diagnosis of PPTD was established in 78 out of 368 who had positive anti-TPO levels and ultrasonographic thyroid structural changes. Twenty-nine of these patients had a transient rise of anti-TPO autoantibodies characterizing an autoimmune reaction. These autoantibodies levels progressively declined or became negative. Moreover none of these patients had evidence for altered thyroid function during the 18-24 months of follow-up. The remaining 49 patients (13.3%) progressively developed thyroid function abnormalities (mainly hypothyroidism) indicating the presence of thyroid gland changes due to PPTD. Further follow-up studies indicated that at 18-24 months, 42 patients had serum levels of anti-TPO-Ab that were more elevated, as compared with the first year values. Predictive factors found during pregnancy for developing PPTD were: (1) relatively low levels of anti-TPO, between 60 and 100 U/ml (odds ratio 3.1 : 1), and (2) ultrasonographic thyroid structural changes in the first trimester (odds ratio 6.4 : 1). CONCLUSIONS: We conclude that the prevalence of postpartum thyroid dysfunction in our geographical area ranges from 6.7% to 13.3%, considering, respectively, all pregnant women that were examined (n = 754) or only the number of puerperal women actually followed-up (n = 368). A transient form of thyroid autoimmune reaction characterized by elevated serum levels of anti-TPO that progressively declined or disappeared was observed in 29 puerperal women. Sonographic structural and echogenicity changes in the thyroid gland and borderline positive anti-TPO levels (between 60 and 100 U/ml) during pregnancy were considered to be of predictive value for development of postpartum thyroid dysfunction.


Subject(s)
Autoimmune Diseases/epidemiology , Puerperal Disorders/epidemiology , Thyroid Diseases/epidemiology , Adolescent , Adult , Autoantibodies/blood , Autoimmune Diseases/diagnosis , Brazil/epidemiology , Female , Follow-Up Studies , Humans , Predictive Value of Tests , Pregnancy , Prevalence , Puerperal Disorders/diagnosis , Risk Factors , Thyroglobulin/blood , Thyroid Diseases/diagnosis , Thyroid Function Tests , Thyroid Gland/diagnostic imaging , Thyroid Gland/immunology , Thyroid Hormones/blood , Ultrasonography
19.
Int J Obes Relat Metab Disord ; 24(11): 1433-7, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11126339

ABSTRACT

OBJECTIVE: In obese men, sex hormone-binding globulin (SHBG) as well as total testosterone (TT) levels are decreased. Data concerning serum free testosterone (FT) levels in obese men are discordant. FT levels are decreased in only some morbidly obese men, consistent with an impairment of the feedback regulatory mechanism. In this study we aimed to verify serum levels of TT and FT in two groups of obese men (BMI < 35.0 kg/m2 and BMI > 35.1 kg/m2) before and after weight loss. DESIGN: Two groups of obese men (group 1: BMI < or = 35 kg/m2; and group 2: BMI > or =35.1 kg/m2) were studied before and after 6 months of a low energy diet (1200 kcal/day). Every patient received a therapeutic prescription of dexfenfluramine (15 mg b.i.d.) that was maintained for 6 months. SUBJECTS: Thirty-seven obese men and 20 normal weight men. MEASUREMENTS: Serum sex hormones (TT and FT), serum luteinizing hormone (LH) and insulin were analyzed by RIA assays. Plasma insulin levels, serum TT, FT and LH concentrations were obtained before and after weight loss. RESULTS: Moderately obese men (BMI = 32.3+/- 1.9 kg/m2) presented significantly decreased TT levels (390+/-120ng/dl) as well as FT (mean+/-s.d.:16.0+/-4.8pg/ml) as compared with normal controls. FT serum levels had a significant and negative correlation with body mass index (BMI), whereas for TT concentrations this correlation was not significant. Serum LH concentrations (4.5+/-2.9mlU/ml) were normal. Insulin levels were elevated in all patients (46.3+/-30.1 microU/ml). After weight loss there was a significant (P< 0.01) increase in TT, FT and LH levels, whereas insulin concentrations significantly decreased. In massively obese men (BMI = 43.0 6.7 kg/m2), TT (320+/-110ng/dl), FT (11.0+/-2.1 pg/ml) and LH (3.1+/-1.3mlU/ml) were decreased and significantly lower as compared with the previous group and normal controls. As expected, after weight loss TT, FT and LH levels increased significantly while insulin concentrations decreased. CONCLUSIONS: We concluded that FT levels are dependent on the degree of obesity, massively obese men (BMI > or =35.1 kg/m2) being considered as candidates for consistently low FT levels. A functional decrease of LH pulse amplitude and serum LH levels as well as a possible negative action of excess of circulating leptin on the steroidogenesis may be related to the decreased androgens levels in massively obese men.


Subject(s)
Dexfenfluramine/administration & dosage , Diet, Reducing , Obesity, Morbid/physiopathology , Testis/physiopathology , Testosterone/blood , Adult , Aged , Body Mass Index , Case-Control Studies , Cohort Studies , Humans , Insulin/blood , Luteinizing Hormone/blood , Male , Middle Aged , Obesity, Morbid/blood , Obesity, Morbid/diet therapy , Radioimmunoassay , Weight Loss/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...